Oncology Institute, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
DEFA14A: The Oncology Institute Sets Date for Annual Stockholders Meeting, Proposes Reverse Stock Split
The Oncology Institute will hold its annual stockholders meeting on May 7, 2025, and is seeking approval for a reverse stock split.
NASDAQ
DEF: The Oncology Institute Sets Date for 2025 Annual Stockholders Meeting, Proposes Reverse Stock Split
The Oncology Institute announces its annual stockholders meeting on May 7, 2025, featuring proposals including the election of directors, ratification of the accounting firm, and a potential reverse stock split.
NASDAQ
The Oncology Institute will hold its annual stockholders meeting on June 13, 2024, to elect directors, ratify the appointment of BDO USA, P.C., and approve the issuance of shares related to convertible notes and warrants.
NASDAQ
DEF 14A: The Oncology Institute Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
The Oncology Institute will hold its annual stockholders meeting virtually on June 13, 2024, to vote on the election of directors, ratification of the independent accounting firm, and approval of potential share issuances related to convertible notes and warrants.